Image

    Update: The Pathogenesis and Treatment of Polycystic Ovary Syndrome

    July 2003 in “ The Nurse practitioner
    Kathryn M Hill
    Studysummary This article reviews diagnostic and management strategies for polycystic ovary syndrome in primary care and reports no new clinical results; it also discusses when specialist referral is appropriate.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Polycystic Ovary Syndrome: Clinical and Biochemical Features New England journal of medicine/˜The œNew England journal of medicine · 1995
    2. A Prospective Randomized Trial Comparing Finasteride to Spironolactone in the Treatment of Hirsute Women The Journal of Clinical Endocrinology and Metabolism · 1995
    3. Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism: A Randomized Controlled Trial Fertility and Sterility · 1994
    4. Spironolactone Is an Effective and Well-Tolerated Systemic Antiandrogen Therapy for Hirsute Women The Journal of Clinical Endocrinology & Metabolism · 1989

    Related research 3

    1. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    2. Ovarian Morphology and Prevalence of Polycystic Ovary Syndrome in Reproductive Aged Women With or Without Mild Acne International Journal of Dermatology · 2010
    3. Update: The Pathogenesis and Treatment of Polycystic Ovary Syndrome The Nurse practitioner · 2003